These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19295197)

  • 1. Dietary and pharmacological control of calcium and phosphate metabolism in predialysis stages of chronic kidney disease.
    Ketteler M; Biggar PH
    Blood Purif; 2009; 27(4):345-9. PubMed ID: 19295197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate Metabolism in CKD Stages 3-5: Dietary and Pharmacological Control.
    Ketteler M
    Int J Nephrol; 2011; 2011():970245. PubMed ID: 21660261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The control of hyperphosphatemia in chronic kidney disease: which phosphate binder?
    Ketteler M
    Int J Artif Organs; 2009 Feb; 32(2):95-100. PubMed ID: 19363781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease.
    Nikolov IG; Mozar A; Drüeke TB; Massy ZA
    Blood Purif; 2009; 27(4):350-9. PubMed ID: 19295198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles of hyperphosphatemia in vascular calcification].
    Shioi A; Nishizawa Y
    Clin Calcium; 2009 Feb; 19(2):180-5. PubMed ID: 19182356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of vascular calcification in CKD patients.
    Massry SG; Smogorzewski M
    Semin Nephrol; 2006 Jan; 26(1):38-41. PubMed ID: 16412824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of hyperphosphatemia among patients with ESRD.
    Coladonato JA
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S107-14. PubMed ID: 16251245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of hyperphosphatemia ; phosphate-binder].
    Yokoyama K
    Clin Calcium; 2009 Feb; 19(2):205-12. PubMed ID: 19182360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of calcium and phosphate metabolism and prevention of vascular calcifications in uremic patients].
    Malberti F; Ravani P
    G Ital Nefrol; 2005; 22 Suppl 31():S47-52. PubMed ID: 15786402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium metabolism in health and disease.
    Peacock M
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S23-30. PubMed ID: 20089499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.
    Cozzolino M; Ciceri P; Volpi EM; Olivi L; Messa PG
    Blood Purif; 2009; 27(4):338-44. PubMed ID: 19295196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of hyperphosphatemia in patients with chronic kidney disease].
    Savica V; Santoro D; Monardo P; Mallamace A; Bellinghieri G
    G Ital Nefrol; 2009; 26 Suppl 46():58-61. PubMed ID: 19644820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case against calcium-based phosphate binders.
    Moe SM; Chertow GM
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):697-703. PubMed ID: 17699275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.
    Toussaint ND; Kerr PG
    Nephrology (Carlton); 2007 Oct; 12(5):500-9. PubMed ID: 17803475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Getting the balance right: assessing causes and extent of vascular calcification in chronic kidney disease.
    Ketteler M; Biggar PH
    Nephrology (Carlton); 2009 Jun; 14(4):389-94. PubMed ID: 19563380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate metabolism in chronic kidney disease: from pathophysiology to clinical management.
    Spasovski G; Massy Z; Vanholder R
    Semin Dial; 2009; 22(4):357-62. PubMed ID: 19708981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate: a stealthier killer than previously thought?
    Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A
    Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.